1. Introduction Epilepsy remains one of the most common neurological disorders worldwide, with a global impact of 65 million people (Beghi, 2020; Kanner and Bicchi, 2022). It is characterized by spontaneous recurrent seizures, and since there is no cure, the primary focus in treating epilepsy is to reduce seizures, often via anti-seizure medications (ASMs). When two tolerated and appropriately prescribed ASMs fail to achieve seizure freedom, the patient is deemed drug-resistant.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Lorena
Contact Lorena, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack